# David Petraeus, Angel Investor

Investor in New York, New York

## About David Petraeus, Angel Investor

David Petraeus is a Partner at a global alternative investment and asset management firm, where he he provides strategic guidance on geopolitical and macroeconomic trends influencing investment and portfolio strategy. Before entering the private sector, he had a distinguished military and public service career, serving as Director of the CIA and as a four-star general in the U.S. Army, where he led coalition forces in Iraq and Afghanistan.

David sits on the boards of Optiv, OneStream Software, and advises companies such as Semperis and Advanced Navigation, bringing deep expertise in leadership, national security, and technology-driven resilience. His focus bridges global strategy with innovation in cybersecurity, AI, and critical infrastructure.

David has made over a dozen investments, including in Clearspeed, Carbyne, and Hypori, reflecting his interest in secure communications, defense technology, and advanced data systems. His portfolio highlights a consistent focus on solutions that enhance safety, intelligence, and operational effectiveness worldwide.

## People

- **David Petraeus**, Angel Investor

## Key Facts

- **Location:** New York, New York
- **Investor Type:** Angel Investor

## Investment Industries

- Defense
- Technology/Web/App
- Other

## How to Contact

Direct messaging and this investor's website are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/david-petraeus-angel-investor
- More investors: [Defense Investors in New York](https://askforfunding.com/site/angel-investors/new-york/defense)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
